Main > INFLUENZA VIRUS > Infection. Treatment > Respiratory Congestion Redn. > Neuraminidase Inhibitor. > H1 Histamine R Antagonist Combi. > Oseltamivir.+ > H1 Histamine R Antagonist Combi. > Patent. > Claims > Claim 1: Dual Release Drug Delivery > Device: 1) Compn.: Oseltamivir & > Excipient; Controlled Release & 2) > H1 Histamine Receptor Antagonist; > Rapid Release. Claim 2: Device > Select: Capsules Etc. Claim 4: > (1): Release Rate Modifier. Claim 5 > : (2): Excipient. Claim 12: Osmotic > Device: a) Core: Oseltamivir (Granu > late) & Osmotic Agent; b) SemiPerme > able Membrane having Passageway > & c) Coat.: H1 Antagonist. Claim > 13: Inert Water Soluble Coat (d) > between (b) & (c). Claim 14: (c) > Sprayed onto (d). Claim 19: > H1 Antagonist Select: Acrivastine; > Fexofenadine, Loratadine Etc. > Claim 24: Core: OsmAgent; Binder & > Diluent. Membrane: Cellulose Ester > & Plasticizer. (d): Water Soluble > Polymer; Opaquant & Filler. (c): > Film Forming Polymer & DisIntegrant > . Claim 25: OsmAgent: NaCl Etc. > Diluent: MicroCrystalline Cellulose > Etc. Binder: Poly(VinylPyrrolidone) > Etc. Cellulose Acetate (Ester) Etc. > Plasticizer: Poly(Ethylene Glycol) > Etc. Water Soluble Polymer:
Etc. Water Soluble Polymer:'s subsections
HydroxyPr MeCellulose Etc.
Etc. Water Soluble Polymer:'s products
This section has no products